NCT00767234终止不适用
Predicting DVT Risk in GI Cancer Patients Using Plasma Biomarkers
适应症
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 入组人数
- 104
- 试验地点
- 1
- 主要终点
- Identify Biomarkers
研究概览
简要总结
To determine whether biomarkers assessed in blood samples can be used to detect individuals at risk for developing blood clots or worsening of their underlying disease. The ultimate goal of the study is to identify key biomarkers derived from blood that are most characteristic and informative of individuals who will go on to develop a clotting complication.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Male or female, >= 18 years old. There are no ethnic restrictions.
- •Active cancers of the GI tract (gastroesophageal, colorectal, or pancreatic-biliary) that have completed TNM staging by the American Joint Committee on Cancer; stage III disease if diagnosed within 2 months and all stage IV disease
- •Ability to understand and the willingness to sign a written informed consent document.
- •Existing staging CT imaging study
排除标准
- •Life expectancy < 6 months
- •History of deep vein thrombosis (DVT) or pulmonary embolism (PE)
- •Known pregnancy or positive urine pregnancy test in pre-menopausal women
- •On anticoagulant therapy (heparin, warfarin, direct thrombin inhibitors)
- •No CT imaging studies, or contraindications to undergoing CT imaging
- •Existing or anticipated need for a tunneled central venous catheter
- •Clinic visitation to Stanford Cancer center for secondary consultation purposes only
- •Inability to give informed consent
结局指标
主要结局
Identify Biomarkers
时间窗: 3 years
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
尚未招募
不适用
Development and Validation of a Risk Prediction Model for Venous Thromboembolism in Gynecological Cancer Patients Undergoing Systemic Antineoplastic Treatment: The Gynecological Cancer Associated Thrombosis (GynCAT) StudyCancer-associated ThrombosisGynecologic CancerCervix CancerEndometrial CancerOvarian CancerVaginal CancerVenous ThromboembolismNCT06284343Fondazione Policlinico Universitario Agostino Gemelli IRCCS1,800
招募中
不适用
Using Biomarkers for Diagnosis, Risk Stratification of Post -Treatment Recurrence and Long-Term Surveillance of Lung CancerAdenocarcinoma of LungNode LungNCT05665504H. Lee Moffitt Cancer Center and Research Institute250
已完成
不适用
D-dimer and Pre-test Clinical Probability Score in Cancer Patients With Suspected Deep Vein Thrombosis of the LegsDeep Vein ThrombosisNCT02341937G. d'Annunzio University239
终止
不适用
Circulating Tumor DNA Alterations in Non-small Cell Lung Cancer Patients Treated With PembrolizumabNon Small Cell Lung CancerNCT04791215Columbia University10
招募中
不适用
Identification of Biomarkers for Patients with Vascular AnomaliesVascular AnomalyGeneralized Lymphatic AnomalyKaposiform HemangioendotheliomaKaposiform LymphangiomatosisGorham-Stout DiseaseKlippel Trenaunay SyndromeCongenital Lipomatous Overgrowth, Vascular Malformations, and Epidermal NeviNCT03001180Children's Hospital Medical Center, Cincinnati1,000